why choose us

First received: June 06, 2023

Clinical Trial: A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Hepatitis C Virus

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Open-label Study to Assess the Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic Hepatitis C Virus (HCV) Infection

Brief Summary: This is an open-label trial to evaluate safety and efficacy of treatment with BEM + RZR in subjects with chronic HCV infection.

Read more